126 related articles for article (PubMed ID: 679682)
1. Plasma levels of norethisterone after single and multiple injections of norethisterone oenanthate.
Fotherby K; Howard G; Shrimanker K; Elder M; Bye PG
Contraception; 1978 Jul; 18(1):1-6. PubMed ID: 679682
[TBL] [Abstract][Full Text] [Related]
2. The effect of injectable norethisterone oenanthate on ovarian hormones in Thai women.
Werawatgoompa S; Vaivanijkul B; Leepipatpaiboon S; Channiyom K; Virutamasen P; Dusitsin N
Contraception; 1980 Mar; 21(3):299-309. PubMed ID: 7389353
[TBL] [Abstract][Full Text] [Related]
3. The effects of intramuscular norethisterone oenanthate used as a contraceptive on intravenous glucose tolerance and on blood coagulation factors VII and X.
Howard G; Myatt L; Elder MG
Br J Obstet Gynaecol; 1977 Aug; 84(8):618-21. PubMed ID: 889752
[TBL] [Abstract][Full Text] [Related]
4. Norethisterone levels in maternal serum and milk after intramuscular injection of norethisterone oenanthate as a contraceptive.
Fotherby K; Towobola O; Muggeridge J; Elder MG
Contraception; 1983 Nov; 28(5):405-11. PubMed ID: 6673900
[TBL] [Abstract][Full Text] [Related]
5. Serum progesterone and norethisterone levels following injection of norethisterone enanthate in different sites and doses.
Joshi JV; Hazari KT; Shah RS; Chadha UC; Chitlange S; Gokral JS; Arolkar SG
Steroids; 1989 Jun; 53(6):751-61. PubMed ID: 2815152
[TBL] [Abstract][Full Text] [Related]
6. Norethisterone enanthate as an injectable contraceptive in puerperal and non-puerperal women.
Melis GB; Strigini F; Fruzzetti F; Paoletti AM; Rainer E; Düsterberg B; Fioretti P
Contraception; 1981 Jan; 23(1):77-88. PubMed ID: 6781816
[TBL] [Abstract][Full Text] [Related]
7. New long-acting injectable microcapsule contraceptive system.
Beck LR; Cowsar DR; Lewis DH; Gibson JW; Flowers CE
Am J Obstet Gynecol; 1979 Oct; 135(3):419-26. PubMed ID: 114054
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of different doses of norethisterone oenanthate.
Fotherby K; Hamawi A; Howard G; Bye PG; Elder M
Contraception; 1984 Apr; 29(4):325-33. PubMed ID: 6744856
[TBL] [Abstract][Full Text] [Related]
9. Serum norethindrone (NET) concentrations following intramuscular NET enanthate injection. Effect upon serum LH, FSH, estradiol and progesterone.
Goebelsmann U; Stanczyk FZ; Brenner PF; Goebelsmann AE; Gentzschein EK; Mishell DR
Contraception; 1979 Mar; 19(3):283-313. PubMed ID: 572279
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of norethisterone, estradiol and progesterone after administration of norethisterone oenanthate at different sites: a cross-over study.
Virutamasen P; Dhanapas S; Leepipatpaiboon S
Asia Oceania J Obstet Gynaecol; 1987 Mar; 13(1):49-53. PubMed ID: 3593083
[No Abstract] [Full Text] [Related]
11. Some metabolic effects of long-term use of the injectable contraceptive norethisterone oenanthate.
Howard G; Blair M; Fotherby K; Trayner I; Hamawi A; Elder MG
Lancet; 1982 Feb; 1(8269):423-5. PubMed ID: 6121092
[No Abstract] [Full Text] [Related]
12. A clinical trial of norethisterone oenanthate (Norigest) injected every two months.
Howard G; Blair M; Chen JK; Fotherby K; Muggeridge J; Elder MG; Bye PG
Contraception; 1982 Apr; 25(4):333-40. PubMed ID: 7049569
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of norethindrone and individual metabolites in human plasma during short- and long-term administration of a contraceptive dosage.
Braselton WE; Lin TJ; Ellegood JO; Mills TM; Mahesh VB
Am J Obstet Gynecol; 1979 Jan; 133(2):154-60. PubMed ID: 369375
[TBL] [Abstract][Full Text] [Related]
14. Serium protein-bound carbohydrate and seromucoid levels during long-acting progestational contraceptive therapy.
Saleh FM
Contraception; 1977 Oct; 16(4):399-407. PubMed ID: 923250
[TBL] [Abstract][Full Text] [Related]
15. A clinical and metabolic study of norethisterone oenanthate in Thai women.
Virutamasen P; Nitichai Y; Tangkeow P; Kankeerati W; Rienprayura D; Boonsiri B
Contraception; 1980 Oct; 22(4):397-408. PubMed ID: 7449388
[TBL] [Abstract][Full Text] [Related]
16. Norethisterone oenanthate as an injectable contraceptive in two treatment schedules in interval subjects.
Gulati K; Mapa MK; Gupta AN; Singh PM; Devi PK
Asia Oceania J Obstet Gynaecol; 1984 Sep; 10(3):281-6. PubMed ID: 6525083
[TBL] [Abstract][Full Text] [Related]
17. Long-term use of depot-norethisterone enanthate: effect on blood coagulation factors and menstrual bleeding patterns.
McEwan JA; Griffin M
Contraception; 1991 Dec; 44(6):639-48. PubMed ID: 1773620
[TBL] [Abstract][Full Text] [Related]
18. Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: noresthisterone oenanthate and medroxyprogesterone acetate. 2. Bleeding patterns and side effects.
Contraception; 1978 May; 17(5):395-406. PubMed ID: 657807
[TBL] [Abstract][Full Text] [Related]
19. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
[TBL] [Abstract][Full Text] [Related]
20. Norethisterone contraceptive microspheres.
Rivera R; Alvarado G; Flores C; Aldaba S; Hernandez A
J Steroid Biochem; 1987; 27(4-6):1003-7. PubMed ID: 3695501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
